
IndraLab
Statements
CACNA1A activates translation. 12 / 12
|
12
reach
"To examine the therapeutic effects of miR-3191-5p-mediated reduction of CACNA1A IRES driven alpha1ACT SCA6 translation on the disease phenotype of SCA6 mice, we constructed an AAV9 vector that allowed for the simultaneous expression of GFP and either miR-3191-5p (AAV9-miR-3191-5p) or a nonspecific mock miRNA (AAV9-miR-mock) (XREF_SUPPLEMENTARY)."
reach
"Because both eIF4AII and eIF4GII affected not only CACNA1A IRES driven translation of alpha1ACT but also cap dependent translation of full-length alpha1A (XREF_FIG), we used IRES-alpha1ACT vectors (XREF_SUPPLEMENTARY) to test the binding affinities of eIF4AII and eIF4GII to CACNA1A IRES."
reach
"Considering that an ~ 50% decrease in the number of Purkinje cells is sufficient to cause ataxia and motor deficits in our mouse model, miRNA mediated alpha1ACT SCA6 silencing by blockade of CACNA1A IRES driven translation in greater than half of Purkinje cells would have great potential benefit in presymptomatic or symptomatic SCA6 patients."